Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8R40

Crystal structure of diabody CR57 in complex with rabies virus protein G domain III

Summary for 8R40
Entry DOI10.2210/pdb8r40/pdb
DescriptorHomospecific Diabody CR57, Glycoprotein, GLYCEROL (3 entities in total)
Functional Keywordsrabies glycoprotein, antibody-antigen complex, cr57 diabody, antibody, engineered antibody, viral protein
Biological sourceHomo sapiens
More
Total number of polymer chains4
Total formula weight83591.12
Authors
Kedari, A.,Rissanen, I. (deposition date: 2023-11-10, release date: 2024-11-06, Last modification date: 2024-12-18)
Primary citationKedari, A.,Iheozor-Ejiofor, R.,Salminen, P.,Ugurlu, H.,Makela, A.R.,Levanov, L.,Vapalahti, O.,Hytonen, V.P.,Saksela, K.,Rissanen, I.
Structural insight into rabies virus neutralization revealed by an engineered antibody scaffold.
Structure, 32:2220-, 2024
Cited by
PubMed Abstract: Host-cell entry of the highly pathogenic rabies virus (RABV) is mediated by glycoprotein (G) spikes, which also comprise the primary target for the humoral immune response. RABV glycoprotein (RABV-G) displays several antigenic sites that are targeted by neutralizing monoclonal antibodies (mAbs). In this study, we determined the epitope of a potently neutralizing human mAb, CR57, which we engineered into a diabody format to facilitate crystallization. We report the crystal structure of the CR57 diabody alone at 2.38 Å resolution, and in complex with RABV-G domain III at 2.70 Å resolution. The CR57-RABV-G structure reveals critical interactions at the antigen interface, which target the conserved "KLCGVL" peptide and residues proximal to it on RABV-G. Structural analysis combined with a cell-cell fusion assay demonstrates that CR57 effectively inhibits RABV-G-mediated fusion by obstructing the fusogenic transitions of the spike protein. Altogether, this investigation provides a structural perspective on RABV inhibition by a potently neutralizing human antibody.
PubMed: 39471803
DOI: 10.1016/j.str.2024.10.002
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

239492

数据于2025-07-30公开中

PDB statisticsPDBj update infoContact PDBjnumon